Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma

Authors: Bart Neyns, Lisa Zimmer, Caroline Robert, Celeste Lebbe, Olivier Michielin, Omid Hamid, Anne Zaremba, Oliver Klein, Ruth Plummer, Joanna Mangana, Paolo A Ascierto, Katharina C Kähler, Georgina V Long, Ryan Sullivan, Grant A McArthur, Michael Weichenthal, Egle Ramelyte, Meghan J Mooradian, Douglas B Johnson, Alexander Shoushtari, Christian U Blank, Judith M Versluis, Prachi Bhave, Claudia Trojanello, Lu Si, Inderjit Mehmi, Tasnia Ahmed, Alexander M Menzies, Adnan Khattak, Severine Roy, Matteo S Carlino, Paul C Lorigan, Clara Allayous, Rachel Roberts-Thomson, Florentia Dimitriou, Kathleen Batty, Thierry Lesimple, Serigne N Lo, Alexandre Wicky, Richard Heywood, Lena Tran, Anna Stansfeld, Julia K Schwarze, Andrea Maurichi, Hui-Ling Yeoh, Mario Santinami, Andrew M Haydon

Source: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 7 (2022)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/10/7/e004668.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/0b1c2b670e1e4ec1b95b97b6b085c47b

A retrospective analysis of eosinophilia as a predictive marker of response and toxicity to cancer immunotherapy

Authors: Tharani Krishnan, Yoko Tomita, Rachel Roberts-Thomson

Source: Future Science OA, Vol 6, Iss 10 (2020)

Subject Terms: biomarker, cancer, eosinophilia, immune checkpoint inhibitors, response, toxicity, Medicine, Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/2056-5623

Access URL: https://doaj.org/article/3e45eddc47b6465bb47189036f0ed854